Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.
Leuk Lymphoma
; 60(9): 2316-2319, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-30712423
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Stem Cell Transplantation
/
Nivolumab
/
Neoplasm Recurrence, Local
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2019
Document type:
Article
Country of publication: